Printed From:

Last update: March 2019

Primary hypercholesterolaemia and mixed dyslipidaemia1

  • PRALUENT is indicated in adults with primary hypercholesterolaemia (heterozygous familial and non-familial) or mixed dyslipidaemia, as an adjunct to diet:
    • in combination with a statin or statin with other lipid-lowering therapies in patients unable to reach LDL-C goals with the maximum tolerated dose of a statin, or
    • alone or in combination with other lipid-lowering therapies in patients who are statin-intolerant or for whom a statin is contraindicated

Established atherosclerotic cardiovascular disease1

  • PRALUENT is indicated in adults with established atherosclerotic cardiovascular disease to reduce cardiovascular risk by lowering LDL-C levels as an adjunct to correction of other risk factors:
    • in combination with the maximum tolerated dose of a statin with or without other lipid-lowering therapies, or
    • alone or in combination with other lipid-lowering therapies in patients who are statin-intolerant or for whom a statin is contraindicated

References